Eric d'Esparbes
2017 - Innoviva
In 2017, Eric d'Esparbes earned a total compensation of $1.9M as Senior Vice President and Chief Financial Officer at Innoviva, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,773 |
|---|---|
| Salary | $441,546 |
| Stock Awards | $1,253,605 |
| Other | $12,000 |
| Total | $1,927,923 |
d'Esparbes received $1.3M in stock awards, accounting for 65% of the total pay in 2017.
d'Esparbes also received $220.8K in non-equity incentive plan, $441.5K in salary and $12K in other compensation.
Rankings
In 2017, Eric d'Esparbes' compensation ranked 5,684th out of 14,666 executives tracked by ExecPay. In other words, d'Esparbes earned more than 61.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,684 out of 14,666 | 61st |
Division Manufacturing | 2,061 out of 5,772 | 64th |
Major group Chemicals And Allied Products | 636 out of 2,075 | 69th |
Industry group Drugs | 490 out of 1,731 | 72nd |
Industry Pharmaceutical Preparations | 385 out of 1,333 | 71st |
Source: SEC filing on March 23, 2018.
d'Esparbes' colleagues
We found four more compensation records of executives who worked with Eric d'Esparbes at Innoviva in 2017.
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019